Mind Medicine (MindMed) (MNMD) News Today $9.40 -0.03 (-0.32%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 8:00 AM | marketbeat.comMind Medicine (MindMed) Inc. to Post Q2 2024 Earnings of ($0.31) Per Share, Roth Capital Forecasts (NASDAQ:MNMD)Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities research analysts at Roth Capital issued their Q2 2024 earnings estimates for shares of Mind Medicine (MindMed) in a report released on Wednesday, July 24th. Roth Capital analyst J. Wittes anticipates that the company will post eJuly 25 at 10:30 AM | americanbankingnews.comMind Medicine (MindMed) (NASDAQ:MNMD) Upgraded to Strong-Buy at Roth CapitalJuly 25 at 8:13 AM | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Raised to "Strong-Buy" at Roth CapitalRoth Capital upgraded shares of Mind Medicine (MindMed) to a "strong-buy" rating in a report on Wednesday.July 24 at 6:31 PM | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading 4.4% Higher Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 4.4%July 24 at 9:30 AM | americanbankingnews.comRoth Mkm Initiates Coverage on Mind Medicine (MindMed) (NASDAQ:MNMD)July 22, 2024 | americanbankingnews.comBrokerages Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Price Target at $20.00July 19, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 5.2% Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 5.2%July 19, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of "Buy" from BrokeragesMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has received an average recommendation of "Buy" from the nine ratings firms that are presently covering the company, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating and one has given a strong buy ratiJuly 17, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 4.2%Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 4.2%July 6, 2024 | investorplace.com3 Psychedelic Stocks to Ride to the Moon and BeyondJuly 4, 2024 | investorplace.comFDA Favorites: 3 Biotech Stocks on the Verge of Major ApprovalsJune 26, 2024 | insidertrades.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Insider Dan Karlin Sells 6,925 SharesJune 26, 2024 | insidertrades.comRobert Barrow Sells 15,659 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) StockJune 25, 2024 | marketbeat.comDan Karlin Sells 6,925 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) StockMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) insider Dan Karlin sold 6,925 shares of the firm's stock in a transaction on Tuesday, June 25th. The stock was sold at an average price of $7.22, for a total transaction of $49,998.50. Following the completion of the sale, the insider now owns 351,527 shares of the company's stock, valued at $2,538,024.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.June 24, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of "Buy" from AnalystsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has been assigned a consensus rating of "Buy" from the nine analysts that are covering the stock, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation and one has issued a strong buJune 21, 2024 | marketbeat.comMind Medicine (MindMed)'s (MNMD) "Overweight" Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating on shares of Mind Medicine (MindMed) in a report on Friday.June 21, 2024 | businesswire.comMindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceJune 20, 2024 | businesswire.comMindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)June 18, 2024 | investorplace.comWall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024June 11, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 5.3%Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 5.3%June 10, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 7.3%Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 7.3% HigherJune 5, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Down to $8.25Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Down to $8.25June 5, 2024 | seekingalpha.comMindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating FactorsJune 5, 2024 | marketbeat.comMind Medicine (MindMed)'s (MNMD) Outperform Rating Reiterated at Royal Bank of CanadaRoyal Bank of Canada reaffirmed an "outperform" rating and set a $22.00 target price on shares of Mind Medicine (MindMed) in a research report on Wednesday.June 5, 2024 | marketbeat.comScotia Capital Inc. Takes $441,000 Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Scotia Capital Inc. bought a new stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 121,756 shares of the company's stock, valued at approximaJune 4, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 7% Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 7%May 31, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.7%Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 5.7% HigherMay 30, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Upgraded to Strong-Buy by Baird R WBaird R W raised shares of Mind Medicine (MindMed) to a "strong-buy" rating in a report on Wednesday.May 29, 2024 | msn.comBaird Initiates Coverage of Mind Medicine (MNMD) with Outperform RecommendationMay 28, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Analysts at Robert W. BairdRobert W. Baird began coverage on Mind Medicine (MindMed) in a research note on Tuesday. They issued an "outperform" rating and a $27.00 target price on the stock.May 28, 2024 | businesswire.comMindMed to Participate in June ConferencesMay 24, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Rating Reiterated by HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $35.00 price objective on shares of Mind Medicine (MindMed) in a research note on Friday.May 23, 2024 | investorplace.comThe Time Traveler's Portfolio: 3 Stocks to Buy Now for Massive Returns by 2034May 23, 2024 | seekingalpha.comPsychedelics Closer To Commercialization; Compass Far And Away The LeaderMay 21, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading 3% Higher Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 3% HigherMay 15, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 5.5%Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 5.5%May 13, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 2.9% Following Analyst DowngradeMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 2.9% on Analyst DowngradeMay 13, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Rating Reaffirmed by OppenheimerOppenheimer restated an "outperform" rating and issued a $20.00 target price (down previously from $29.00) on shares of Mind Medicine (MindMed) in a research report on Monday.May 10, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) PT Lowered to $35.00HC Wainwright cut their target price on Mind Medicine (MindMed) from $75.00 to $35.00 and set a "buy" rating on the stock in a research report on Friday.May 10, 2024 | investorplace.comTop Russell 2000 Picks: 3 Small-Cap Stocks to Scoop Up This MayMay 9, 2024 | businesswire.comMindMed to Participate at May Investor ConferencesMay 9, 2024 | finance.yahoo.comNew Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the USMay 9, 2024 | investorplace.comBiotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing MedicineMay 8, 2024 | finance.yahoo.comMindMed Reports First Quarter 2024 Financial Results and Business UpdatesMay 6, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 5.4% Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 5.4%May 4, 2024 | businesswire.comMindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New YorkMay 3, 2024 | marketbeat.comMind Medicine (MindMed) (MNMD) Scheduled to Post Earnings on WednesdayMind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports.May 2, 2024 | businesswire.comMindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business UpdateApril 29, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.9%Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 5.9%April 26, 2024 | seekingalpha.comMindMed: Breakthrough Status From The FDA For LSD Therapy Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address “Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event. You can find out what they are by clicking here now. MNMD Media Mentions By Week MNMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNMD News Sentiment▼0.810.61▲Average Medical News Sentiment MNMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNMD Articles This Week▼112▲MNMD Articles Average Week Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TLRY News CRON News USNA News CGC News BTMD News ACB News CDXC News MDWD News FTLF News BGXX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNMD) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
